Pharma
Post-Acquisition Compliance Integrated Across Two Enterprise Environments. Zero Audit Findings.
Kite Pharma
Role
Decentralized IT infrastructure across Kite Pharma and Gilead requiring full unification under a single Security Operations Center, while manufacturing timelines stayed on track
Strict FDA GxP commissioning and qualification across all manufacturing and laboratory systems, with zero tolerance for audit disruptions
Disjointed cybersecurity policies, operational procedures, and cross-functional workflows spanning Kite, Gilead, and third-party vendors
Solution
Algorama deployed a compliance engine to parse, map, and standardize heterogeneous policies and procedures across both entities. Automated blueprinting established compliant SOPs for Disaster Recovery, GxP, SOX, and data privacy. Cross-functional milestones across Kite, Gilead, and third-party vendors were tracked through automated timeline orchestration.
Key Wins
100% adherence to FDA standards across all critical manufacturing and laboratory systems.
Post-acquisition security integration accelerated through automated platform consolidation into the centralized Gilead SOC.
Complex cross-functional technical teams migrated onto uniform, automated Agile delivery frameworks.
Tech Stack:
AWS Cloud Service
Carbon Black
SNYPR
Guardium
Jamf